Oncoinvent ASA (KLDVK) — Cash Flow Reinvestment Rate
Latest as of December 2025:
0.58x
Oncoinvent ASA (KLDVK) has a Cash Flow Reinvestment Rate of 0.58x as of December 2025, reinvesting Nkr2.12 Million (capex Nkr2.12 Million ) from operating cash flow of Nkr3.64 Million. See KLDVK FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
0.58x
(Capex + Investments) / Operating CF
Total Reinvested
Nkr2.12 Million
Capex + Investments
Operating Cash Flow
Nkr3.64 Million
NOK
Capital Expenditures
Nkr2.12 Million
NOK
Oncoinvent ASA Cash Flow Reinvestment Rate (2021–2022)
Historical reinvestment intensity for Oncoinvent ASA across 2 annual periods. For the full cash flow conversion analysis, see KLDVK cash flow conversion.
Annual Cash Flow Reinvestment Rate for Oncoinvent ASA (2021–2022)
Year-by-year capital reinvestment analysis for Oncoinvent ASA. See financial agility of Oncoinvent ASA to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (NOK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 32.49x | Nkr12.12 Million | Nkr373.06K | Nkr12.12 Million | ▼ -86.3% |
| 2021 | 236.36x | Nkr30.88 Million | Nkr130.66K | Nkr30.88 Million | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow